Revenue rose to Rs 2,265 crore from Rs 1,928 crore in the October-December quarter of last fiscal, Fortis Healthcare said in a statement.
PAT for the third quarter includes an exceptional loss of Rs 55.2 crore, which relates to the one-time impact of new labor laws, offset by reversal of impairment in an associate of Rs 9.4 crore, resulting in a net impact of Rs 45.9 crore, the report said.
“We have witnessed healthy growth in our hospital operations across all major specialties, especially renal sciences and orthopedics, which grew by 27 percent and 20 percent respectively over the corresponding previous period,” said Fortis Healthcare MD and CEO Ashutosh Raghuvanshi.
The acquisition of the Bengaluru-based company will enable it to strengthen its presence in this market from around 900 beds across seven facilities, with the potential to scale up to over 1,500 beds in the future, he added.
“We continue to move forward with our brownfield expansion plans and evaluate further inorganic opportunities in our existing clusters,” Raghuvanshi said. The continued recovery in both sales and EBITDA margin for the diagnostics business is encouraging, and the company expects this to improve gradually, he said.
The company’s shares ended 1.22 percent lower at Rs 916.90 apiece on BSE on Friday.
#Fortis #Healthcare #results #Net #profit #declines #crore